Observational studyClinical rheumatology2021

Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis.

Natalia Mena-Vázquez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.